454 related articles for article (PubMed ID: 25703333)
1. Placebo and nocebo responses in drug trials of epilepsy.
Zaccara G; Giovannelli F; Schmidt D
Epilepsy Behav; 2015 Feb; 43():128-34. PubMed ID: 25703333
[TBL] [Abstract][Full Text] [Related]
2. Adverse events, placebo and nocebo effects in placebo-treated paediatric patients with refractory focal epilepsies. Analysis of double-blind studies.
Zaccara G; Giovannelli F; Franco V; Cincotta M; Tramacere L; Verrotti A
Epilepsy Res; 2014 Dec; 108(10):1685-93. PubMed ID: 25288026
[TBL] [Abstract][Full Text] [Related]
3. Analysis of nocebo effects of antiepileptic drugs across different conditions.
Zaccara G; Giovannelli F; Giorgi FS; Franco V; Gasparini S
J Neurol; 2016 Jul; 263(7):1274-9. PubMed ID: 26810717
[TBL] [Abstract][Full Text] [Related]
4. Placebo and nocebo reactions in randomized trials of pharmacological treatments for persistent depressive disorder. A meta-regression analysis.
Meister R; Jansen A; Härter M; Nestoriuc Y; Kriston L
J Affect Disord; 2017 Jun; 215():288-298. PubMed ID: 28363152
[TBL] [Abstract][Full Text] [Related]
5. Clinical features associated with placebo response in refractory focal epilepsy.
Schmidt D; Beyenburg S; D'Souza J; Stavem K
Epilepsy Behav; 2013 May; 27(2):393-8. PubMed ID: 23490458
[TBL] [Abstract][Full Text] [Related]
6. Placebo and Nocebo Responses in Pharmacological Trials of Tic Disorders: A Meta-Analysis.
Wang S; Xiong Z; Cui Y; Fan F; Zhang S; Jia R; Hu Y; Li L; Zhang X; Han F
Mov Disord; 2024 Mar; 39(3):585-595. PubMed ID: 38247265
[TBL] [Abstract][Full Text] [Related]
7. Nocebo Responses in Brain Diseases: A Systematic Review of the Current Literature.
Zis P; Mitsikostas DD
Int Rev Neurobiol; 2018; 139():443-462. PubMed ID: 30146057
[TBL] [Abstract][Full Text] [Related]
8. Nocebo effect in refractory partial epilepsy during pre-surgical monitoring: Systematic review and meta-analysis of placebo-controlled clinical trials.
Zis P; Shafiq F; Mitsikostas DD
Seizure; 2017 Feb; 45():95-99. PubMed ID: 27978485
[TBL] [Abstract][Full Text] [Related]
9. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
10. The Placebo and Nocebo Phenomena: Their Clinical Management and Impact on Treatment Outcomes.
Chavarria V; Vian J; Pereira C; Data-Franco J; Fernandes BS; Berk M; Dodd S
Clin Ther; 2017 Mar; 39(3):477-486. PubMed ID: 28237673
[TBL] [Abstract][Full Text] [Related]
11. Placebo and nocebo effects in the neurological practice.
Bittar C; Nascimento OJ
Arq Neuropsiquiatr; 2015 Jan; 73(1):58-63. PubMed ID: 25608129
[TBL] [Abstract][Full Text] [Related]
12. Placebo and nocebo responses in randomized controlled trials of Janus kinase inhibitor monotherapy for rheumatoid arthritis : A meta-analysis.
Sung YK; Lee YH
Z Rheumatol; 2022 Jun; 81(5):430-437. PubMed ID: 33687525
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the adverse events profile of placebo-treated patients in randomized controlled trials on drug-resistant focal epilepsies.
Giovannelli F; Zaccara G; Cincotta M; Loiacono G; Verrotti A
J Neurol; 2015 Jun; 262(6):1401-6. PubMed ID: 25311571
[TBL] [Abstract][Full Text] [Related]
14. Adverse events attributable to nocebo in randomized controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy: systematic review.
Häuser W; Bartram C; Bartram-Wunn E; Tölle T
Clin J Pain; 2012 Jun; 28(5):437-51. PubMed ID: 22336767
[TBL] [Abstract][Full Text] [Related]
15. Placebo responses in randomized trials of antiepileptic drugs.
Guekht AB; Korczyn AD; Bondareva IB; Gusev EI
Epilepsy Behav; 2010 Jan; 17(1):64-9. PubMed ID: 19919904
[TBL] [Abstract][Full Text] [Related]
16. Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: systematic review and meta-analysis.
Häuser W; Sarzi-Puttini P; Tölle TR; Wolfe F
Clin Exp Rheumatol; 2012; 30(6 Suppl 74):78-87. PubMed ID: 23137770
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice.
Kravvariti E; Kasdagli MI; Diomatari KM; Mouratidou P; Daskalakis K; Mitsikostas DD; Sfikakis PP; Yavropoulou MP
Osteoporos Int; 2023 Mar; 34(3):585-598. PubMed ID: 36596944
[TBL] [Abstract][Full Text] [Related]
18. Placebo and nocebo responses in randomised, controlled trials of medications for ADHD: a systematic review and meta-analysis.
Faraone SV; Newcorn JH; Cipriani A; Brandeis D; Kaiser A; Hohmann S; Haege A; Cortese S
Mol Psychiatry; 2022 Jan; 27(1):212-219. PubMed ID: 33972692
[TBL] [Abstract][Full Text] [Related]
19. Nocebo in clinical trials for depression: a meta-analysis.
Mitsikostas DD; Mantonakis L; Chalarakis N
Psychiatry Res; 2014 Jan; 215(1):82-6. PubMed ID: 24210741
[TBL] [Abstract][Full Text] [Related]
20. Nocebo effects and psychotropic drug action.
Amanzio M
Expert Rev Clin Pharmacol; 2015 Mar; 8(2):159-61. PubMed ID: 25494811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
